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Abstract 19 
Sea anemone venoms have long been recognized as a rich source of peptides with interesting 20 
pharmacological and structural properties, but they still contain many uncharacterized bioactive 21 
compounds. Here we report the discovery, three-dimensional structure, activity, tissue localization, and 22 
putative function of a novel sea anemone peptide toxin that constitutes a new, sixth type of voltage-23 
gated potassium channel (KV) toxin from sea anemones. Comprised of just 17 residues, k-actitoxin-24 
Ate1a (Ate1a) is the shortest sea anemone toxin reported to date, and it adopts a novel three-dimensional 25 
structure that we have named the Proline-Hinged Asymmetric b-hairpin (PHAB) fold. Mass 26 
spectrometry imaging and bioassays suggest that Ate1a serves a primarily predatory function by 27 
immobilizing prey, and we show this is achieved through inhibition of Shaker-type KV channels. Ate1a 28 
is encoded as a multi-domain precursor protein that yields multiple identical mature peptides, which 29 
likely evolved by multiple domain duplication events in an actinioidean ancestor. Despite this ancient 30 
evolutionary history, the PHAB-encoding gene family exhibits remarkable sequence conservation in 31 
the mature peptide domains. We demonstrate that this conservation is likely due to intra-gene concerted 32 
evolution, which has to our knowledge not previously been reported for toxin genes. We propose that 33 
the concerted evolution of toxin domains provides a hitherto unrecognized way to circumvent the effects 34 
of the costly evolutionary arms race considered to drive toxin gene evolution by ensuring efficient 35 
secretion of ecologically important predatory toxins. 36 
 37 
Introduction 38 
Venoms are complex cocktails of bioactive molecules that disrupt the physiology of envenomated prey 39 
[1, 2]. Although these toxins include a wide range of molecules, such as proteins, peptides, polyamines, 40 
and salts, the impressive molecular diversity of most invertebrate venoms is due to disulfide-rich 41 
peptides [3]. In animals that rely on venom for prey capture, diet and foraging ecology are thought to 42 
be major drivers of toxin evolution, with the acquisition of resistance in prey countered by diversifying 43 
selection acting on toxin genes in the predator [4]. As a result, the venoms of predatory animals tend to 44 
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be highly diverse, often containing hundreds to thousands of unique bioactive toxins [3]. One such 45 
group is sea anemones, which are benthic, sessile cnidarians that use venom for a variety of ecological 46 
functions, including prey capture, defence, digestion, and inter- and intraspecific competition. 47 
Given the ecological importance of venom in sea anemones, and the fact that the cnidarian venom 48 
system has been evolving for >700 million years [5], it is not surprising that sea anemones have evolved 49 
a rich variety of venom toxins including enzymes, cytolysins, and neurotoxins[6, 7]. Of these, disulfide-50 
rich peptide neurotoxins constitute the largest molecular diversity. According to the classification 51 
system proposed by Mikov and Kozlov [8], at least 17 different peptide folds have been identified in 52 
sea anemone venoms [9], although recent proteomics studies suggest that they likely contain 30 or more 53 
[10]. 54 
In addition to being the most diverse components of sea anemone venoms, neuroactive peptides are 55 
also the most well studied. They have been used as tools for probing ion channel structure and function, 56 
and for developing novel therapies [7]. For example, ShK, a venom peptide from the sea anemone 57 
Stichodactyla helianthus, recently completed Phase 1 clinical trials for treatment of autoimmune disease 58 
[11]. Neurotoxins from sea anemone venoms act on a diverse range of ion channels, including acid-59 
sensing ion channels (ASIC), transient receptor potential ion (TRP) channels, and voltage-gated sodium 60 
(NaV) and potassium (KV) channels. Of these, KV toxins are the most diverse group, comprising 136 of 61 
the 320 annotated sea anemone toxins in UniProtKB. These KV toxins are currently divided into five 62 
distinct types based on their sequence, disulfide-bridge pattern, and activity [12]. 63 
Here we describe the structure, activity, function and evolution of a new, sixth type of sea anemone KV 64 
toxin. k-Actitoxin-Ate1a (henceforth Ate1a), from venom of the Waratah sea anemone Actinia 65 
tenebrosa, is the shortest sea anemone toxin reported to date, and it adopts a novel b-hairpin-like 3D 66 
fold. In contrast with many b-hairpin peptides, Ate1a lacks antimicrobial activity and instead serves a 67 
predatory function via potent inhibition of prey KV channels. While most families of predatory toxins 68 
evolve via bursts of extensive duplication and diversification, this is not the case for the Ate1a toxin 69 
family, whose members remain remarkably well conserved despite their ancient evolution. Our data 70 
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suggest that this extreme conservation is due to intra-gene concerted evolution, a process that has to our 71 
knowledge not been previously reported for any toxin family and which we propose is a hitherto 72 
unrecognised mechanism of maintaining efficient secretion of ecologically important toxins. 73 
 74 
Materials and Methods 75 
Venom Collection and Fractionation 76 
Sea anemones were housed in aquaria at The University of Queensland. Animals were kept for no 77 
longer than two months prior to any experiments, and the average conditions for the system where the 78 
animals were kept were: 10 hours light, 14 hours dark; salinity was 35.9 ppt; pH 8.22, and 29.19 °C. 79 
Venom was obtained by electrical stimulation [13] and fractionated using reverse-phase HPLC as 80 
described previously [10]. 81 
Mass Spectrometry 82 
Peptide masses in lyophilised HPLC fractions were analysed using MALDI-TOF MS (AB SCIEX 5800 83 
MALDI-TOF/TOF mass spectrometer). HPLC fractions were mixed 1:1 (v/v) with α-cyano-4-hydroxy-84 
cinnamic acid (7.5 mg/mL in 50/50 acetonitrile (ACN)/H2O, 0.1% trifluoroacetic acid. Mass spectra 85 
were collected in reflector positive mode. 1,5-Diaminonaphthalene was used as a reductive matrix [14] 86 
to sequence intact Ate1a by ISD MS. The sample was mixed 1:1 (v/v) with 1,5-diaminonaphthalene (15 87 
mg/mL in 50/50 ACN/H2O, 1% formic acid, and spectra were interpreted manually.  88 
MALDI-MSI was performed according to published protocols [15, 16] using an UltraFlex III (Bruker-89 
Daltonik, Bremen, Germany). On-tissue reduction and alkylation of cystines was carried out on de-90 
paraffinised tissue sections using a volatile reaction protocol as described [17], but with a 3.5 mL 91 
reaction volume in a 50 mL Corning Falcon tube (Thermo Fisher Scientific). 92 
For ultra-high mass resolution MSI we used a SolariX XR 7T FT-ICR mass spectrometer (Bruker-93 
Daltonik, Bremen, Germany) was used and operated in the positive ion mode. Data size was set to 1M 94 
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across the mass range 400–6000 m/z. MALDI source was set to a laser power = 50%, a total of 500 95 
shots per scan at a frequency of 2kHz, smart walk was enabled with a width of 90 µm. The Collision 96 
Cell RF Frequency was set to 1.4 MHz, Collision RF Amplitude 1100 Vpp, Transfer Optics Time of 97 
Flight = 1.5 ms at a frequency of 2 MHz with RF Amplitude = 400 Vpp. The sweep excitation was set 98 
to 20%. For isotopic fine structure analysis, data size was set to 4M across the mass range 200–3000 99 
m/z. Data was collected and averaged across 8 scans. MALDI source was set to a laser power = 50%, 100 
a total of 5000 shots per scan at frequency of 2 kHz, the laser was manually moved across sample area. 101 
For isolation the quadrupole was set to 1890.00 with an isolation window of 5 m/z. The Collision Cell 102 
RF Frequency was set to 2 MHz and Collision RF Amplitude set to 1200 VPP. The Transfer Optics 103 
were set to a Time of flight = 1.5 ms, Frequency set to 4 MHz with RF Amplitude set to 400 Vpp. 104 
Sweep excitation set to 19%. For data analysis Bruker (Bruker-Daltonik, Bremen, Germany) 105 
DataAnalysis 5.0 and for image analysis Bruker FlexImaging 5.0 and Bruker SCiLS Lab 2017a were 106 
used. 107 
Transcriptomics 108 
Total RNA extraction by TRIzol, cDNA library preparation, transcriptome sequencing, read trimming, 109 
and assembly was performed as described previously [10]. Raw sequence reads (SRA) and Trinity-110 
assembled contigs were deposited with links to BioProject accession number PRJNA414357 in the 111 
NCBI BioProject database (www.ncbi.nlm.nih.gov/bioproject/). CDSs were identified using the Galaxy 112 
tool ‘Get open reading frames or coding sequences’ [18]. The Ate1a sequence determined using ISD-113 
MALDI-MS was used to search the translated transcriptome using NCBI BLAST+ blastp [19]. 114 
Evolution of Ate1a 115 
The Ate1a prepropeptide sequence was used to search for homologues in UniProtKB, NCBI nr and 116 
EST, and a tentacle transcriptome of S. haddoni [10] using NCBI BLAST+ blastp. Nucleotide 117 
sequences were retrieved and aligned using mafft v7.304b [20] domains were extracted using CLC 118 
Main Workbench v7.6.1 and maximum likelihood phylogenies reconstructed with IQ-Tree v1.5.5 [21] 119 
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for each domain type. The evolutionary model (FLU+G4) was determined using ModelFinder [22], and 120 
support values estimated by ultrafast bootstrap using 10000 iterations [23]. 121 
Ate1a Synthesis 122 
Ate1a (H-RCKTCSKGRCRPKPNCG-NH2) was assembled using Fmoc chemistry (0.1 mmol scale) on 123 
a Symphony automated peptide synthesiser (Protein Technologies) on Fmoc-Rink-amide polystyrene 124 
resin. Amino acid couplings, Fmoc deprotections, and removal of side-chain protecting groups were 125 
achieved using published protocols [24]. Side-chain protecting groups were: Arg(Pbf), Asn(Trt), 126 
Cys(Trt), Lys(Boc), Ser(tBu) and Thr(tBu). The crude product (ESI-MS m/z: calc. (avg) 632.1 127 
[M+3H]3+, found 632.0) was oxidatively folded by stirring in 0.1 M NH4HCO3 (pH 8.1) at room 128 
temperature for 3 days to give a single major isomer that was isolated by preparative HPLC (ESI-MS 129 
m/z: calc. (avg) 630.8 [M+3H]3+, found 631.0). 130 
NMR structure determination of Ate1a 131 
The solution structure of Ate1a was determined using 2D NMR spectroscopy. Spectra of synthetic 132 
Ate1a (1 mM in 20 mM sodium phosphate, pH 6, 5% D2O) were acquired at 10°C on a cryoprobe-133 
equipped Avance 600 MHz spectrometer (Bruker BioSpin). Resonance assignments were made using 134 
2D 1H-1H TOCSY, 2D 1H-1H NOESY spectra, and natural abundance 2D 1H-15N HSQC and 1H-13C 135 
HSQC spectra. Spectra were analysed using CcpNmr Analysis v2.4.1 [25]. Resonance assignments 136 
(97.8% complete) have been deposited in BioMagResBank (accession number 30342). Dihedral-angle 137 
restraints were derived using TALOS-N [26] and the restraint range set to twice the estimated standard 138 
deviation. The NOESY spectrum was manually peak-picked, then 96.3% of the peak list was 139 
automatically assigned, and structures calculated using CYANA v3.97 [27] The final structure was 140 
calculated using 66 interproton distance restraints, 6 disulfide-bond restraints and 23 dihedral-angle 141 
restraints. 200 structures were calculated, then the 20 with highest stereochemical quality as judged by 142 
MolProbity were used to represent the solution structure of Ate1a. Atomic coordinates are available 143 
from the Protein Data Bank (accession code 6AZA). 144 
Electrophysiological characterisation of Ate1a 145 
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The pharmacological effect of Ate1a was analysed by heterologous expression of rKV1.1, rKV1.2, 146 
hKV1.3, rKV1.4, rKV1.5, rKV1.6, Shaker IR, rKV2.1, hKV3.1, rKV4.2, hKV7.2, hKV11.1, rNaV1.2, 147 
rNaV1.3, rNaV1.4, hNaV1.5, mNaV1.6, hNaV1.7, rNaV1.8, rASIC1a, rASIC1b, rASIC2a, and rASIC3 in 148 
Xenopus laevis oocytes, with lowercase r, m and h indicating the channel is of rat, mouse or human 149 
origin, respectively. The linearized plasmids were transcribed using the T7 or SP6 mMESSAGE-150 
mMACHINE transcription kit (Ambion, Waltham, MA, USA). The KV1.1 triple mutant channel was 151 
constructed as previously describes [28]. Oocytes were injected with 50 nL of cRNA at a concentration 152 
of 0.05–1 ng/nL using a micro-injector (Drummond Scientific, Broomall, PA, USA). Injected oocytes 153 
were stored at 19 °C in an ND96 solution (in mM: 96 NaCl, 2 KCl, 1.8 CaCl2, 2 MgCl2 and 5 HEPES; 154 
pH 7.4), supplemented with 50 µg/mL gentamicin sulfate. 155 
Two-electrode voltage-clamp recordings were performed at room temperature (18–22 °C) using a 156 
Geneclamp 500 or Axoclamp 900A amplifier (Molecular Devices, Sunnyvale, CA, USA) controlled by 157 
a pClamp data acquisition system (Axon Instruments, Union City, CA, USA). Whole cell currents from 158 
oocytes were recorded 1–5 days after injection, when a whole cell current could be observed. The bath 159 
solution composition was ND96 (in mM: 2 NaCl, 96 KCl, 1.8 CaCl2, 2 MgCl2 and 5 HEPES; pH 7.4). 160 
Voltage and current electrodes were filled with KCl (3 M). The resistance of both electrodes was kept 161 
between 0.8 and 1.0 MΩ. KV currents were filtered at 0.5 or 2 kHz using a four-pole low-pass Bessel 162 
filter, and leak subtraction was performed using a −P/4 protocol. KV1.1−KV1.6 and Shaker IR currents 163 
were evoked by 500 ms depolarization to 0 mV followed by a 500 ms pulse to −50 mV, from a holding 164 
potential of −90 mV. KV2.1, KV3.1, KV4.2 and KV4.3 currents were elicited by 500 ms pulses to +20 mV 165 
from a holding potential of −90 mV. Current traces of hERG channels were elicited by applying a +40 166 
mV pulse for 2.5 s followed by a step to −120 mV for 2.5 s. NaV currents were evoked by 100 ms 167 
depolarization pulse from a holding potential of −90 mV to −20 mV, with the exception of NaV1.8 168 
which were pulsed to 0 mV. NaV data were digitized at 20 kHz; leak and background conductance were 169 
identified by blocking channels with tetrodotoxin and subtracted from currents. ASIC currents were 170 
acquired (digitized 2 kHz and filtered at 0.01 Hz) and elicited by a drop in pH from 7.45 to 6.5, 5.5, 171 
4.5, and 6.3 (for ASIC1a, ASIC1b, ASIC2a, and ASIC3, respectively).  172 
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Due to the lack of a hNaV1.1 clone for oocyte screening, activity on this channel was assessed via 173 
manual patch-clamp electrophysiology. HEK293 cells heterologously expressing hNaV1.1 (SB Drug 174 
Discovery, Glasgow, UK) were maintained at 37 °C in a humidified 5% CO2 incubator in minimal 175 
essential medium supplemented with 10% FBS v/v, 2 mM L-glutamine and selection antibiotics as 176 
recommended by the manufacturer. Cells were grown to 70–80% confluence and passaged every 2–4 177 
days using Detachin (Genlantis, San Diego, CA, USA). Whole cell patch-clamp recordings were 178 
obtained using a MultiClamp 700B amplifier (Molecular Devices, Sunnyvale, CA, USA). Patch pipettes 179 
were pulled from standard wall borosilicate glass capillaries (1.5 mm x 0.86 mm, OD/ID; SDR 180 
Scientific, Sydney, AUS) using a microelectrode puller (P-97; Sutter Instrument Co., Novato, CA, 181 
USA) and had a resistance of 1.2–1.5 MW when filled with pipette solution. The pipette solution was 182 
composed of (in mM) 150 CsCl, 1 EGTA, 10 HEPES and was adjusted to pH 7.2 with CsOH. The 183 
external bath solution consisted of (in mM) 140 NaCl, 4 KCl, 1 MgCl2, 2 CaCl2, 10 HEPES and adjusted 184 
to pH 7.4 with NaOH. Currents were monitored for at least 5 min after establishing whole-cell 185 
configuration to allow currents to stabilize. The pulse protocol consisted of cells being held at -90 mV 186 
for 10 s, followed by a hyperpolarizing step to -120 mV for 200 ms, then a depolarizing step to -15 mV 187 
for 50 ms. Series resistance and prediction compensation between 50–75% was applied to reduce 188 
voltage errors. Recorded currents were acquired with a Digidata 1550B (Molecular Devices) converter 189 
at 50 kHz after passing through a low-pass Bessel filter of 10 kHz. A P/6 subtraction protocol provided 190 
by the Clampex (Molecular Devices) acquisition software was used to remove linear leak and residual 191 
capacitance artifacts. 192 
Ate1a concentration–response relationships data were fitted with the Hill 193 
equation y = 100/[1 + (IC50/[toxin])h], where y is the amplitude of the toxin-induced effect, IC50 is the 194 
toxin concentration at half-maximal efficacy, [toxin] is the toxin concentration and h is the Hill 195 
coefficient. In order to investigate the current–voltage (I–V) relationship, current traces were evoked by 196 
10 mV depolarization steps from a holding potential of −90 mV. The values of IK were plotted as 197 
function of voltage and fitted using the Boltzmann equation IK/Imax = [1 + exp(Vg − V)/k]−1, 198 
where Imax represents maximal IK, Vg is the voltage corresponding to half-maximal current and k is the 199 
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slope factor. To assess the concentration dependence of the Ate1a induced inhibitory effects, a 200 
concentration–response curve was constructed in which the percentage of current inhibition was plotted 201 
as a function of toxin concentration. Data were fitted with the Hill equation. All data represent at least 202 
three independent experiments (n ≥ 3) and are presented as mean ± standard error. Comparison of two 203 
sample means was made using a paired Student's t test (P < 0.05). All data were analyzed 204 
using clampfit 10.3 (Molecular Devices) and origin 7.5 software (Origin Lab., Northampton, MA, 205 
USA). 206 
Antimicrobial activity of Ate1a 207 
Antimicrobial screening was performed by the Community for Antimicrobial Drug Discovery (CO-208 
ADD) (www.co-add.org). Inhibition of growth was measured against five bacteria: Escherichia coli 209 
(ATCC 25922), Klebsiella pneumoniae (ATCC 700603), Acinetobacter baumannii (ATCC 19606), 210 
Pseudomonas aeruginosa (ATCC 27853) and Staphylococcus aureus (MRSA; ATCC 43300), and two 211 
fungi: Candida albicans (ATCC 90028) and Cryptococcus neoformans (ATCC 208821), following 212 
protocols previously described [Page 5, Supplementary Information in 29]. 213 
Susceptibility of red blood cells and cultured cells to Ate1a 214 
Hemolytic assays employed erythrocytes isolated from fresh human blood collected from healthy 215 
donors using protocols approved by the Human Research Ethics Committee at The University of 216 
Queensland. Hemolysis was quantified as described [30] by measuring hemoglobin release at 405 nm, 217 
with melittin and cyclic gomesin as controls. The cytotoxicity of Ate1a was determined against HeLa, 218 
MCF-7, and HFF-1 cell cultures using a resazurin colorimetric assay [31], with melittin and cyclic 219 
gomesin as positive controls. 220 
Interactions of Ate1a with lipid bilayers 221 
Surface plasmon resonance (SPR) was used to monitor the affinity of Ate1a for lipid membranes using 222 
a Biacore 3000 instrument (GE healthcare) and an L1 chip at 25ºC. Synthetic POPC (1-palmitoyl-2-223 
oleoyl-sn-glycero-3-phosphocholine) and POPS (1-palmitoyl-2-oleoyl-sn-glycero-3-phosphoserine) 224 
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(Avanti polar lipids) were used to prepare small unilamellar vesicles (SUVs, 50 nm diameter) composed 225 
of POPC or POPC/POPS (4:1 molar ratio) dispersed in HEPES buffer (10 mM HEPES containing 150 226 
mM NaCl, pH 7.4) and homogenized by extrusion. The L1 chip possesses a dextran coat modified with 227 
alkyl chains to allow attachment of liposomes and formation of lipid bilayers. SUVs were injected onto 228 
an L1 chip for 40 min at a flow rate of 2 µL/min; the signal reached a steady state below 10,000 response 229 
units in the four flow channels confirming coverage of the chip surface and formation of stable bilayers. 230 
Serial two-fold dilutions of Ate1a, starting from 64 µM, were injected over deposited lipid bilayers for 231 
180 s at a flow rate of 5 µL/min (association phase); dissociation was followed for 600 s [32, 33]. An 232 
N-to-C cyclized version of gomesin (UniProtKB P82358) was included for comparison. The chip was 233 
regenerated as before [34]. All solutions were freshly prepared and filtered using a 0.22 µm filter; 234 
HEPES buffer was used as running buffer. Response units were normalized to peptide-to-lipid ratio 235 
(P/L) as previously described [32]. 236 
Toxicity of Ate1a In vivo 237 
Toxicity of Ate1a to brine shrimps (A. salina) and amphipods (family Talitridae) was examined as 238 
previously described [35, 36]. For assays where the toxin was dissolved in medium, synthetic Ate1a 239 
was dissolved to a concentration of 0.5 mg/mL in filtered artificial seawater. Assays were performed in 240 
24-well plates for shrimps and 6-well plates for amphipods (Thermo-Fisher Scientific). Paralysis and 241 
lethality were assessed by microscopic observation and responsiveness to contact with a 10 µL plastic 242 
tip. Bovine serum albumin (5 mg/mL) was dissolved in the medium to be used as control (no toxicity). 243 
For injection assays, Ate1a was diluted with a physiological solution for crustaceans (in mM: NaCl 244 
470.4, KCl 8.0, CaCl2 18.0, MgCl21.5, NaHCO3 6.0 and glucose 5.6). The injection volume was 9.4 245 
nL. Groups of ten amphipods (4.35–11.53 mg) were challenged with 5.3 mM of toxin and observed for 246 
mortality or paralysis up to 4 h. Controls were amphipods that were not injected or were injected with 247 
crustacean physiological solution. 248 
 249 
 250 
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 251 
Results 252 
Discovery of Ate1a 253 
Specimens of A. tenebrosa were collected off the coast of North Stradbroke Island, Queensland, 254 
Australia (27°15 S, 153°15 E), and venom obtained by electrical stimulation[10]. Fractionation of 255 
venom using reversed-phase chromatography revealed a conspicuous early-eluting peak containing an 256 
unusually low-mass component (Fig. 1a), which we confirmed to be a disulfide-rich peptide by de novo 257 
sequencing using in-source dissociation (ISD) matrix-assisted laser desorption/ionization mass 258 
spectrometry (MALDI MS) (Fig. 1b). The toxin, which we named Ate1a, is a 17-residue peptide with 259 
two disulfide bonds and an amidated C-terminus (RCKTCSKGRCRPKPNCG-NH2), yielding a 260 
monoisotopic mass of 1887.93 Da. Ate1a is a novel peptide with no BLAST hits in UniProtKB or NCBI 261 
databases. 262 
To confirm the amino acid sequence of Ate1a and identify any venom homologues, we generated a 263 
transcriptome from tentacles actively regenerating venom, as described previously [10]. De novo 264 
assembly with Trinity yielded 87,485 contigs, which translated to 457,470 potential coding sequences 265 
(CDS). A BLAST search was used to identify the transcript encoding Ate1a, and this returned a single 266 
contig containing a partial CDS with multiple copies of a peptide domain encoding a sequence identical 267 
to that determined by ISD-MALDI-MS. Analysis of remapped reads revealed that this contig represents 268 
two unique transcripts whose CDS differ by two synonymous and two non-synonymous mutations in 269 
the propeptide regions of the Ate1a preproprotein (Figure S1, NCBI SRA accession SRR6282389). 270 
Ate1a belongs to a novel peptide family that evolves by intra-gene concerted evolution 271 
We used the complete sequence of the Ate1a precursor to search for related sequences. A BLAST search 272 
against the UniProtKB and GenBank nr databases returned no significant hits, but BLAST searches 273 
against the NCBI expressed sequence tag (EST) database returned one full-length and two partial Ate1a-274 
like prepropeptide sequence in Anemonia viridis. Similarly, a BLAST search against our published 275 
tentacle transcriptome from Stichodactyla haddoni [10] yielded three unique contigs, including one full-276 
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length prepropeptide. These species include two separate families (Actiniidae and Stichodactylidae), 277 
suggesting that the Ate1a toxin-gene family arose in a common ancestor of the superfamily Actinioidea 278 
[37]. 279 
All identified Ate1a-like prepropeptides are comprised of the same set of domains separated by dibasic 280 
cleavage sites: a signal peptide, one or two cysteine-containing propeptide domains, and three cysteine-281 
free propeptide domains that each precede an Ate1a-like domain (Fig. 2a). The domain architecture is 282 
also the same for all prepropeptides except for the position of the cysteine-containing propeptide, which 283 
in Stichodactylidae (S. haddoni) is found as a single copy immediately following the signal peptide, but 284 
in Actiniidae (A. tenebrosa and A. viridis) exists as two copies that each follow the first two Ate1a-like 285 
domains. This suggests that the Ate1a precursor gene underwent early domain duplication events 286 
followed by either multiple domain deletions or convergent deletions and duplications. Strikingly, 287 
however, the domains share almost 100% nucleotide identity with corresponding domains within the 288 
same prepropeptide (Fig. 2b). Phylogenetic analysis revealed that domains from each species form well-289 
supported clades with respect to those from other species (Fig. 2c). This suggests that the extreme 290 
sequence conservation observed in domains of the Ate1a gene family is due to concerted evolution, an 291 
evolutionary phenomenon that, to our knowledge, has previously only been demonstrated for a single 292 
animal toxin gene family [38], but never for within-gene toxin domains. 293 
Ate1a defines a new peptide fold 294 
The unique primary structure of Ate1a prompted us to characterise its solution structure using NMR 295 
spectroscopy. We synthesised Ate1a using solid phase peptide synthesis and confirmed correct folding 296 
of the synthetic product by HPLC co-elution with native peptide (Fig. S2). 297 
The 3D structure of Ate1a (Fig. 3) was determined using homonuclear NMR methods, and statistics for 298 
the ensemble of structures are shown in Supplementary Table 1. MolProbity analysis [39] revealed that 299 
the structure has excellent stereochemical quality, with no steric clashes and ~90% of residues in the 300 
most favoured Ramachandran region. The precision of the structure, however, is not very high 301 
(backbone RMSD 1.11± 0.28 Å), suggesting that it is highly dynamic, particularly within the longer 302 
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loop 3. This may be due the presence of two proline residues, which leads Ate1a to adopt two distinct 303 
conformations (Fig. 3a). Both conformations adopt a fold similar to that of b-hairpin-like peptides[40], 304 
where the C- and N- termini are connected via two semi-parallel disulfide bonds (C1-C4 and C2-C3). 305 
One face of the toxin has a high proportion of positively charged residues (Fig. 3b) whereas the opposite 306 
face is rich in hydrophobic residues (Fig. 3c).  307 
Although Ate1a displays a hairpin-like structure (Fig. 4a), it is neither a true hairpin scaffold nor similar 308 
to any other previously described hairpin-like peptide fold. The two disulfide-enclosed loops of Ate1a 309 
differ substantially in length, with loop 1 containing just two residues compared to five in loop 3. In 310 
combination with the two prolines in loop 3, this asymmetry prevents the formation of secondary 311 
structures characteristic of other disulfide-enclosed hairpin-like structures such as b-hairpin 312 
antimicrobial peptides (AMPs) [40] (Fig. 4b) or the cystine-stabilised a/a (CSaa) fold [41] (Fig. 4c). 313 
Ate1a also differs from other hairpin-like folds found in animal toxins, such as the boundless b-hairpin 314 
(BBH) [42] (Fig. 4d) and disulfide-directed hairpin (DDH) fold[43] (Fig. 4e), or the two-disulfide fold 315 
of RhTx from venom of the centipede Scolopendra subspinipes[44] (Fig. 4f). Thus, Ate1a is the 316 
prototypic member of a previously undescribed peptide fold that we coined the Proline-hinged 317 
asymmetric b-hairpin-like (PHAB) fold. 318 
Ate1a represents a new type of sea anemone KV-toxin  319 
Many Arg/Lys-rich, disulfide-stabilised b-hairpin peptides (e.g., gomesin and tachyplesin-1) function 320 
as AMPs in the innate immune system. They often have high affinity for lipid membranes and possess 321 
both anticancer and antimicrobial activity [29]. Although Ate1a does not adopt a typical b-hairpin fold, 322 
it is highly positively-charged. However, Ate1a had no antimicrobial activity at concentrations up to 323 
256 µg/mL. Similarly, Ate1a was not cytotoxic or cytolytic against cultured human cancer cell lines or 324 
erythrocytes (Fig. S3). Consistent with these results, Ate1a displayed only weak affinity for, and rapid 325 
dissociation from, lipid membranes compared to gomesin [45] (Fig. S4). Taken together, Ate1a’s lack 326 
of antimicrobial and cytolytic activity, as well as its low affinity for lipid membranes, suggests that it 327 
does not play a role in defence against pathogens. 328 
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Ion channels are the most common molecular target of disulfide-rich venom peptides, and we therefore 329 
used electrophysiology to screen Ate1a against eight NaV channels, twelve KV channels, and four ASIC 330 
subtypes. Ate1a was found to selectively target several members of the Shaker subfamily of KV 331 
channels; at 3 µM it inhibited currents mediated by KV1.1 (84% ± 4%), KV1.2 (94% ± 3%), KV1.3 332 
(38% ± 4%), KV1.6 (92% ± 2%), and Shaker IR (23% ± 2%) channels (Fig. 5a). No activity was 333 
observed on other channels at the same concentration (Fig. S5). Fitting of the Hill equation to 334 
concentration–response curves for KV1.1, KV1.2, KV1.3 and KV1.6 yielded IC50 values of 353 nM, 146 335 
nM, 3051 nM and 191 nM, respectively (Fig. 5b). Thus, given its unique sequence and structure, Ate1a 336 
represents a new, sixth type of sea anemone KV toxin. 337 
Ate1a is a toxin with a predatory function 338 
Although the pharmacological activity of a toxin can provide clues to its ecological function, it is not 339 
by itself definitive. However, the near-universal distribution of nematocytes in the epithelium of sea 340 
anemones means that toxin function can be inferred from tissue distribution [46-48]. We therefore 341 
investigated the tissue distribution of Ate1a using MALDI-MS imaging (MSI), which allows 342 
visualization of the spatial distribution of unlabelled low mass biomolecules (1–20 kDa)[15, 16, 49]. A 343 
peak corresponding to the average mass of Ate1a was clearly observed in MALDI-TOF-MSI spectra 344 
acquired from cross-sectioned A. tenebrosa. The identity of this peak was further supported by on-tissue 345 
gas-phase reduction and alkylation, which resulted in a peak shift matching the alkylation of four 346 
cystines (Fig. 6a). Finally, ultra-high mass resolution analysis by MALDI-FT-ICR-MSI allowed us to 347 
fit the predicted isotope structure of Ate1a to the observed spectra and confirm its identity (Fig. 6b). 348 
MSI revealed that Ate1a is non-uniformly distributed within the body of A. tenebrosa, with almost 349 
exclusive localization in tentacles (Fig. 6c), suggesting that it is involved in prey capture. Ate1a mass 350 
signals were weak or absent in actinopharynx, mesenterial filaments, and gastrovascular cavity, 351 
indicating that Ate1a does not play a role in prey digestion. Moreover, A. tenebrosa normally retracts 352 
its tentacles in response to disturbances, and thus the weak Ate1a signal in the trunk region indicates it 353 
is not primarily involved in defence. 354 
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In addition to nematocytes, sea anemones also produce toxins in ectodermal gland cells [50]. Unlike 355 
nematocytes, which are stinging cells that inject venom, gland-cell toxins are released into the water 356 
and absorbed by prey. To determine which cell type produces Ate1a, we conducted toxicity bioassays 357 
using brine shrimp and amphipods, the latter being a major prey item of Actinia spp. [51, 52]. Injection 358 
of Ate1a into amphipods resulted in impaired swimming followed by contractile paralysis 359 
(Supplementary material S1). In contrast, Ate1a did not affect either species when dissolved into the 360 
medium (artificial sea water) (Supplemental videos S1 and S2). Taken together, our data suggest that 361 
Ate1a is a neurotoxin produced in nematocytes and used primarily for prey capture. 362 
Discussion 363 
Although sea anemone venoms are a rich source of bioactive peptides, recent omics studies have 364 
highlighted how little we still know about their composition, function, and evolution [10, 48]. Here we 365 
described the discovery and functional characterization of a new peptide class from venom of the sea 366 
anemone A. tenebrosa, one of the most commonly encountered sea anemones in intertidal zones around 367 
Australia and New Zealand [53]. Ate1a has a primary structure unlike any previously described peptide, 368 
and assumes a unique 3D fold that is reminiscent of b-hairpin AMPs [40]. 369 
In contrast to β-hairpin AMPs, the 3D structure of Ate1a is devoid of regular secondary structure. 370 
Instead, the asymmetry of the two sides of the β-hairpin-like structure of Ate1a prevents β-sheet 371 
formation, and distinguishes the 3D structure from previously described two-disulfide peptide folds 372 
(Fig. 4). The longer of the two ‘loops’ is also highly dynamic (Fig. 3a), a property facilitated by the 373 
presence of two prolines that are conserved in all identified Ate1a homologues. Proline-containing 374 
peptides have the ability to populate two discrete conformations, and this cis-trans conformational 375 
switch works like a hinge that can potentially serve as a precise regulator of biological function [54, 376 
55]. While proline hinges play a diversity of roles in protein biology, one of these roles is reorienting 377 
surface loops to modulate protein binding surfaces and in turn ligand recognition [56]. Thus, we predict 378 
that the proline-hinged loop of Ate1a represents a region that is important for the function of this toxin 379 
family. Given the structural and likely functional importance of this structural feature, we named this 380 
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new structural scaffold the “proline-hinged asymmetric b-hairpin-like” (PHAB) fold. 381 
Reflecting the structural distinctiveness of the PHAB fold from β-hairpin-like peptides, Ate1a does not 382 
have antimicrobial, antifungal, or cytolytic activity, nor strong affinity for lipid membranes (Fig. S2). 383 
Instead, it is a potent inhibitor of Shaker-type KV channels, with nanomolar potency on KV1.1, KV1.2 384 
and KV1.6. KV channels play crucial roles in neuronal signalling, muscle contraction, and secretion [57], 385 
and hence they are a common target of animal toxins. Many venomous taxa have convergently evolved 386 
toxins that target KV channels to induce paralysis, general hyperexcitability, cardiac disorders, 387 
convulsions and death [1]. This is also the case in sea anemones, where KV toxins are represented by 388 
five unique peptide folds: ShK (type 1), Kunitz-domain (type 2), b-defensin-like (type 3), boundless b-389 
hairpin (type 4), and an unknown fold predicted to form an inhibitor cystine knot (type 5)[12]. The 390 
PHAB fold is unlike any of these structural scaffolds, and therefore it represents a new, sixth type of 391 
sea anemone KV toxin. 392 
Although Ate1a is a novel KV toxin, correlating toxin activity with ecological function is often not 393 
straightforward [58]. However, like other cnidarians, sea anemones lack a centralised venom delivery 394 
system, and instead rely on localised production of toxins to complement their functional anatomy [46-395 
48]. In A. tenebrosa, toxins are produced in five tissues and regions that have distinct ecological 396 
functions: acrorhagi (aggressive intraspecific encounters), tentacles (prey capture and immobilisation), 397 
mesenteric filaments (used principally in digestion), column (external defence after retracting 398 
tentacles), and actinopharynx (prey immobilisation and digestion). In addition, sea anemones produce 399 
toxins in two distinct cell types that deliver venom by either injection (nematocytes) or absorption 400 
following secretion into the water column (gland cells)[50]. Ate1a is found predominantly in the 401 
tentacles of A. tenebrosa (Fig. 6), which is suggestive of a predatory function. Moreover, Ate1a 402 
impaired swimming and led to paralysis and death when injected in amphipods, a major prey of Actinia 403 
species, but had no effect when dissolved into the medium. We conclude that Ate1a is a predatory toxin 404 
that cannot reach its KV targets without being inoculated into prey by nematocysts. 405 
Venom proteins are thought to evolve via toxin recruitment events, whereby a gene encoding a normal 406 
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body protein is duplicated and expressed in the venom-producing tissue [4]. Functionally important 407 
toxin types are reinforced through duplication and diversification, and this is considered a hallmark of 408 
toxin evolution in predatory venoms, where toxins evolve continuously to counter acquisition of prey 409 
resistance [4]. Although recent research suggests that venoms evolve via a two-step process in which 410 
initial rapid toxin diversification is followed by periods of purifying selection due to the metabolic costs 411 
of diversifying selection [59, 60], predatory toxins nevertheless tend to be part of large, highly diverse 412 
gene families. Strikingly, however, this diversity is entirely absent in the PHAB gene family, despite 413 
their likely role in predation. Instead, its members are highly conserved and consist of just 2–3 almost 414 
identical copies in each species (Fig. 2b).  415 
The sequence conservation at the nucleotide level is not limited to between-gene copies of each species, 416 
but extends to the domains encoded by each transcript. Despite the emergence and domain duplication 417 
of the PHAB fold in an actinioidean ancestor, all four domain types (signal peptide, two propeptide 418 
domains, and PHAB domain; Fig. 2a) are remarkably well conserved. Furthermore, the nucleotide 419 
sequences encoding each domain type are more similar to the respective domains contained on the same 420 
transcript than to corresponding domain copies in other species (Fig. 2c). This form of domain 421 
conservation is likely to have occurred by concerted evolution, an evolutionary process driven by 422 
continuous recombination that results in homogenisation of genetic variance across gene copies and so-423 
called ‘horizontal evolution’ [61]. Although concerted evolution has been described for a number of 424 
gene families, including NaV Type I toxins from Nematostella vectensis and Actinia equina [38], it is 425 
considered rare for intra-gene protein domain repeats [62], and has never previously been reported 426 
within toxin gene domains. 427 
In contrast with the general view of gene duplication as a facilitator of toxin gene diversification, recent 428 
studies have suggested that gene duplication may be of immediate importance for increased expression 429 
levels rather than generation of sequence diversity [63]. Similarly, the concerted evolution of NaV Type 430 
I toxins from N. vectensis and A. equina has been suggested to confer a selective advantage through a 431 
‘dosage’ effect of gene expression [38]. In the PHAB gene family, this lack of high gene-copy numbers 432 
is compensated for by encoding multiple, identical toxin precursors, thereby effectively multiplying 433 
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toxin expression levels. Concerted evolution may also facilitate ‘transmission’ of advantageous 434 
mutations from a single toxin gene locus to other loci, or preventing the loss of highly effective toxins. 435 
Reflecting this, concerted evolution of protein domain repeats has been proposed to be triggered by 436 
arms-race type co-evolution [62]. 437 
Interestingly, similarly conserved domain repeats were also identified by Honma and colleagues [64] 438 
for the BBH-like AmeI (GenBank accession AB180685) from the venom of the sea anemone 439 
Antheopsis maculata, which is encoded on the same transcript as six repeats that share near-identical 440 
nucleotide sequences. Although further work is required to determine whether these domains evolve by 441 
concerted evolution, their identical nature suggests that intra-gene concerted evolution may in 442 
anemones not be restricted to PHAB toxins. Thus, concerted evolution of toxin-domain repeats may 443 
provide a hitherto unrecognised mechanism of circumventing the effects of the metabolically expensive 444 
evolutionary arms race typically considered to drive toxin gene evolution. In the case of Ate1a and other 445 
members of the PHAB family, this has led to efficient secretion through high domain copy numbers of 446 
structurally unusual but ecologically important, predatory KV toxins. 447 
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Figures and legends 634 
 635 
Fig. 1 Isolation and sequencing of Ate1a. (a) C18 RP-HPLC chromatogram showing fractionation of 636 
crude A. tenebrosa venom. The early-eluting peak containing Ate1a is highlighted in red. Inset shows 637 
average mass and isotope family for Ate1a. (b) De novo sequencing of Ate1a using ISD-MALDI MS 638 
 639 
  640 
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 641 
Fig. 2 Domain architecture and evolution of Ate1a precursors. (a) Domain architecture of Ate1a 642 
and Ate1a-like contigs. Prepropeptides are composed of a signal peptide (SignalP), one or two cysteine-643 
containing propeptide domains (CysProP), and three cysteine-free propeptide domains (LinearProP) 644 
that each precede an Ate1a-like PHAB domain. (b) Nucleotide sequence alignments for each domain. 645 
(c) Maximum likelihood phylogenetic reconstructions for each domain. Bootstrap support values are 646 
shown at the nodes, while horizontal bars indicate genetic distance. Sequence accessions are for S. 647 
haddoni (1–3) TR75252_c0_g2_i1–3 and A. viridis (1) FK754894, (2) FK726055, and (3) FK733314. 648 
See also Figure S1 649 
	 26	
 650 
Fig. 3 3D structure of Ate1a. (a) Solution structure of Ate1a (ensemble of 20 structures; PDB code 651 
6AZA). Disulfide bonds are highlighted in orange and proline side chains are shown in blue. (b) Surface 652 
representation of Ate1a with cationic and uncharged residues shown in blue and grey, respectively. (c) 653 
Surface representation of Ate1a showing relative hydrophobicity, which increases from white to red. 654 
See also Figure S2 and Table S1 655 
 656 
 657 
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 659 
Fig. 4 Ate1a is the first member of the new PHAB fold. Comparison of the PHAB fold with other 660 
peptide folds containing two disulfide bonds and a similar number of residues (16-29 residues). 661 
Disulfide bonds are shown as orange tubes and N- and C-termini are labelled. (a) Ate1a; (b) b-hairpin 662 
fold represented by the spider peptide gomesin (PDB 1KFP); (c) CS α/α motif represented by the 663 
scorpion toxin k-hefutoxin1 (PDB 1HP9); (d) Boundless b-hairpin motif represented by sea anemone 664 
toxin π-AnmTX Ugr 9a-1 (PDB: 2LZO); (e) Disulfide-directed hairpin represented by scorpion toxin 665 
U1-Liotoxin-Lw1a (PDB 2KYJ); (f) Unstructured two-disulfide peptide fold represented by centipede 666 
toxin RhTx (PDB 2MVA) 667 
 668 
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 670 
Fig. 5 Electrophysiological characterization of KV isoforms inhibited by Ate1a. (a) Representative 671 
whole-cell current traces obtained from KV channels expressed in Xenopus oocytes in the absence 672 
(control) and presence (*) of 3 µM Ate1a. (b) Concentration-response curves obtained by plotting 673 
current inhibition as a function of increasing Ate1a concentration. See also Figures S3–S5 and Table 674 
S2 675 
 676 
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 678 
Fig. 6 Tissue distribution of Ate1a determined using MSI. (a) MSI linear positive mode spectra 679 
acquired from a cross-sectioned animal, with peaks corresponding to Ate1a filled in. The spectrum of 680 
native tissue is blue while the spectrum obtained after on-tissue gas-phase reduction and alkylation is 681 
shown in red. Inset shows a mass difference of 180 Da, corresponding to ethanolylation of four cysteine 682 
residues. (b) Ultra-high mass resolution analysis of the peak corresponding to Ate1a acquired by 683 
MALDI-FT-ICR-MSI at a resolution of 16,000,000 and resolving power at 1890 m/z of > 500,000, 684 
showing observed (top) and calculated (bottom) spectra. (c) Left: Histological image of the sea anemone 685 
section used for MSI experiments, stained with hematoxylin and eosin. Right: distribution of the peak 686 
corresponding to the average mass of Ate1a as observed by MALDI-TOF MSI. See also Supplemental 687 
videos S1 and S2 688 
